Fitch: Optum-Change merger won’t lower UnitedHealth’s rating

Most Recent

• If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine?
• Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers
• Poll: Nearly Half of American Adults Now Want the Covid Vaccine — ASAP
• Poll: Half Of U.S. Wants Covid-19 Vaccine ‘As Soon As Possible’
• Under 30 Alum Mammoth Biosciences To Develop Diagnostics For Department Of Defense